Assembly Biosciences, Inc. reported its financial results for the third quarter ended September 30, 2026. Cash, cash equivalents and marketable securities were $314.3 million as of September 30, 2026, compared to $320.4 million as of June 30, 2026. The company’s cash positi
Assembly Biosciences, Inc. Reports Third Quarter 2026 Financial Results and Recent Updates
Assembly Biosciences, Inc. reported its financial results for the third quarter ended September 30, 2026. Cash, cash equ...
By Dhallo News · November 13, 2026 at 7:08 PM IST
Have feedback on this article?Report error or suggestion
